Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

SIG-1451 could be a promising new treatment for atopic dermatitis.

The document corrects a mistake by stating that pimecrolimus, not tacrolimus, is the drug that concentrates in the skin.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Switching to a twice-weekly betamethasone treatment led to full hair regrowth in alopecia areata without side effects.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Baricitinib shows promise in treating severe hair loss.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.